Patch-testing for the management of hypersensitivity reactions to second-line anti-tuberculosis drugs: a case report

Background The second-line anti-tuberculosis drugs used in the treatment of multidrug-resistant tuberculosis often cause adverse events, especially in patients co-infected with the human immunodeficiency virus. Severe hypersensitivity reactions due to these drugs are rare and there is little published experience to guide their management.